Received Nov 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | UNK | Y012227 | — |
No additional AEs were reported; The healthcare worker is reporting that a patient received improperly stored vaccine.; This spontaneous report was received from other health professional and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant therapies, previous drugs reactions and allergies were not reported. On 02-Jun-2025, the patient was vaccinated with an improperly stored dose of hepatitis a vaccine, inactivated (VAQTA) suspension for injection, administered as prophylaxis (Lot No. Y012227 has been verified to be a valid lot number for [hepatitis a vaccine, inactivated], expiration date not reported, but upon internal validation established as 12-Nov-2025) (strength, dose number, exact dose quantity volume, route and anatomical location of administration and vaccination scheme frequency were not provided); after a temperature excursion of 31.3 degree Fahrenheit (F) during a time frame of 15 minutes. No previous temperature excursion was reported. No additional adverse events were reported (no adverse event). No further information provided.